Blar i Department of Clinical Medicine på forfatter "Aabakken, Lars"
-
Gastroparesis Symptoms Associated with Intestinal Hypomotility: An Explorative Study Using Wireless Motility Capsule
Bekkelund, Mattis; Sangnes, Dag André; Søfteland, Eirik Wigtil; Aabakken, Lars; Biermann, Martin; Steinsvik, Elisabeth K.; Hausken, Trygve; Dimcevski, Georg; Hatlebakk, Jan Gunnar (Journal article; Peer reviewed, 2021)Objective: Gastric emptying measurements are mandatory in gastroparesis diagnostics, but the association between delayed emptying and symptoms is questionable. It is imperative to find biomarkers better correlated to symptom ... -
Pathophysiology of idiopathic gastroparesis and implications for therapy
Bekkelund, Mattis; Sangnes, Dag André; Hatlebakk, Jan Gunnar; Aabakken, Lars (Peer reviewed; Journal article, 2019)Objectives: Idiopathic gastroparesis is a gastric motility disorder characterized by chronic upper gastrointestinal symptoms and delayed gastric emptying without an identifiable underlying condition. This review summarizes ... -
Patient-Reported Outcome Measures after Endoscopic Retrograde Cholangiopancreatography: A Prospective, Multicenter Study
Glomsaker, Tom Birger; Hoff, Geir; Kvaløy, Jan Terje; Søreide, Kjetil; Aabakken, Lars; Søreide, Jon Arne; The Norwegian Gastronet ERCP group (Journal article, 2013)Objective: While patient-reported outcome measures (PROMs) in ERCP are scarce, these reports are important for making improvements in quality of care. This study sought to document patient satisfaction and specifically ... -
Randomised clinical trial and meta-analysis: mesalazine treatment in irritable bowel syndrome—effects on gastrointestinal symptoms and rectal biomarkers of immune activity
Castro Tejera, Valeria; Öhman, Lena; Aabakken, Lars; Fellström, Bengt; Hausken, Trygve; Hovde, Øistein; Hreinsson, Johann P.; Lindberg, Greger; Venge, Per; Simrén, Magnus; Törnblom, Hans (Journal article; Peer reviewed, 2022)Background Low-grade immune activation in the gut is a potential treatment target in irritable bowel syndrome (IBS). Aims To determine improvement in IBS symptoms after mesalazine treatment, and the utility of measures ...